JPMorgan Chase & Co. Grows Stake in Avanos Medical, Inc. (NYSE:AVNS)

JPMorgan Chase & Co. grew its position in Avanos Medical, Inc. (NYSE:AVNS) by 6.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 69,571 shares of the company’s stock after buying an additional 4,472 shares during the quarter. JPMorgan Chase & Co. owned 0.15% of Avanos Medical worth $1,672,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Geode Capital Management LLC lifted its stake in Avanos Medical by 1.5% in the third quarter. Geode Capital Management LLC now owns 1,054,162 shares of the company’s stock worth $25,337,000 after acquiring an additional 16,065 shares during the period. Foundry Partners LLC raised its holdings in shares of Avanos Medical by 1.1% in the 3rd quarter. Foundry Partners LLC now owns 163,030 shares of the company’s stock valued at $3,918,000 after purchasing an additional 1,800 shares in the last quarter. AQR Capital Management LLC lifted its position in shares of Avanos Medical by 21.0% in the 2nd quarter. AQR Capital Management LLC now owns 146,983 shares of the company’s stock worth $2,875,000 after purchasing an additional 25,467 shares during the period. FMR LLC lifted its position in shares of Avanos Medical by 34.6% in the 3rd quarter. FMR LLC now owns 133,844 shares of the company’s stock worth $3,216,000 after purchasing an additional 34,421 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Avanos Medical by 12.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 108,470 shares of the company’s stock valued at $2,607,000 after purchasing an additional 11,613 shares in the last quarter. Institutional investors own 95.17% of the company’s stock.

Avanos Medical Price Performance

Shares of AVNS stock opened at $15.88 on Thursday. The company has a market cap of $729.75 million, a P/E ratio of 46.70 and a beta of 0.99. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. The stock’s 50-day moving average is $17.17 and its 200 day moving average is $20.72. Avanos Medical, Inc. has a 1-year low of $14.98 and a 1-year high of $25.36.

Analyst Ratings Changes

Separately, StockNews.com lowered Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.